Reported 3 days ago
Novartis has announced plans to invest $23 billion in expanding its manufacturing and research facilities in the United States, which is expected to create approximately 4,000 additional jobs. This initiative aims to allow the company to produce all of its key medicines domestically amidst growing concerns about potential tariffs on imported pharmaceuticals. Novartis is notably the first EU-based firm to make such a significant commitment in response to these trade threats.
Source: YAHOO